Brazilian study tracks Real-World COPD control with triple inhaler
NCT ID NCT07406048
First seen Feb 20, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study follows about 400 adults with severe COPD in Brazil who are already using the Trimbow® inhaler. Researchers will track their symptoms and lung function over 6 months to see how well the medication controls the disease in everyday practice. The goal is to understand real-world effectiveness, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Santa Casa de Misericórdia de São Paulo
RECRUITINGSão Paulo, São Paulo, 01221-020, Brazil
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.